Euro zone business activity shrinks but Covid vaccine hopes boost optimism

The bloc's economy is on track for its first double-dip recession in nearly a decade as a second wave of the coronavirus sweeps across Europe, a Reuters poll suggested last week

Euro zone business activity shrinks but Covid vaccine hopes boost optimism
Shares and oil prices rose on Monday while the dollar softened.
Jonathan Cable | Reuters London
2 min read Last Updated : Nov 24 2020 | 1:12 AM IST
Eurozone business activity contracted sharply this month as renewed lockdowns forced many firms in the bloc’s dominant service industry to close temporarily, although news of possible vaccines boosted hopes for 2021, surveys showed on Monday.

The bloc's economy is on track for its first double-dip recession in nearly a decade as a second wave of the coronavirus sweeps across Europe, a Reuters poll suggested last week. But on Monday, Britain's AstraZeneca said its vaccine could be around 90 per cent effective without any serious side effects.

Pfizer and Moderna have also developed apparently effective vaccines and Monday’s Purchasing Managers’ Index (PMI) showed optimism about the year ahead improving to its highest since before the pandemic hit the continent.

Still, IHS Markit’s headline flash composite PMI, seen as a good guide to economic health, fell to 45.1 in November from October's 50.0 — the level separating growth from contraction. A Reuters poll had predicted a shallower dip to 46.1.

“The drop in the composite PMI to well below 50 adds to the evidence that the Eurozone economy will post another sizeable contraction in Q4,” said Jack Allen-Reynolds at Capital Economics. But with vaccines looking increasingly likely to be rolled out in the first half of next year, the surveys show greater optimism about 2021."

Vaccine hopes, and expectations of more stimulus from the European Central Bank next month, meant optimism improved. The composite future output index jumped to 60.1 from 56.5, its highest since February.

Shares and oil prices rose on Monday while the dollar softened.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Euro zoneEurope economyCoronavirus VaccineAstraZenecaPMI

Next Story